Previous 10 | Next 10 |
Shares of MacroGenics (NASDAQ: MGNX) surged today, ahead of the May 13 release of abstracts of presentations scheduled for the American Society of Clinical Oncology meeting at the end of the month. Investor optimism that the abstracts will reveal promising data for the company's early-s...
Gainers: Cellect Biotechnology (NASDAQ: APOP ) +77% . More news on: Cellect Biotechnology Ltd., MyoKardia, Inc., Remark Holdings, Inc., Stocks on the move, , Read more ...
Last week, shares of these three biotech stocks rocketed higher, but their market values are still relatively small. That has intrepid investors wondering if their recent gains could be the beginning of something much larger. Data source: Yahoo! Finance. It isn't unusual to see small-cap...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
The following slide deck was published by MacroGenics, Inc. in conjunction with their 2020 Q1 earnings Read more ...
Image source: The Motley Fool. Macrogenics Inc (NASDAQ: MGNX) Q1 2020 Earnings Call May 5, 2020 , 4:30 p.m. ET Operator Continue reading
After MacroGenics (NASDAQ: MGNX) updated investors on its clinical-stage drug pipeline and current financial position, its shares are soaring 171% as of 12:45 am EDT Wednesday. MacroGenics' lead drug candidate is margetuximab, an optimized formulation of the top-selling breast cancer d...
Gainers: MacroGenics (NASDAQ: MGNX ) +171% . More news on: MacroGenics, Inc., CPS Technologies Corporation, Cars.com Inc., Stocks on the move, , Read more ...
MacroGenics ( MGNX +92.9% ) zooms northward on a healthy 16x surge in volume in response to its Q1 report released after the close yesterday. Highlights: More news on: MacroGenics, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
MacroGenics, Inc. (MGNX) Q1 2020 Earnings Conference Call May 5, 2020 04:30 PM ET Company Participants Anna Krassowska - VP, IR and Corporate Communications Scott Koenig - President and CEO Jim Karrels - SVP, CFO and Secretary Conference Call Participants Christopher Marai ...
News, Short Squeeze, Breakout and More Instantly...
SAN FRANCISCO, July 19, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges MacroGenics, Inc. (NASDAQ: MGNX) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/mgnx Contact the Firm Now: MGNX@hbsslaw.com 844-916...
MacroGenics, Inc. (NASDAQ: MGNX) is the focus of IBN's latest stock spotlight. The company's shares have moved 1.07% on the day to $4.7. MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved pr...
SAN FRANCISCO, July 03, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges MacroGenics, Inc. (NASDAQ: MGNX) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/mgnx Contact the Firm Now: MGNX@hbsslaw.com 844-916...